Meridian Bioscience Stock

Meridian Bioscience Current Liabilities

The Current Liabilities of Meridian Bioscience (VIVO) as of Sep 11, 2026 is 57.95 M USD. In the previous year, Current Liabilities was 47.16 M USD — a change of 22.89% (higher).

Current Liabilities

57.95 MUSD

YoY

22.89%

Last updated:

Current Liabilities of Meridian Bioscience is 2026 57.95 M USD. Current Liabilities of Meridian Bioscience was 2025 47.16 M USD. It decreases by 22.89% higher compared to the previous year.

The Meridian Bioscience Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2015
15.20 M USD
Jan 1, 2016
22.60 M USD
Jan 1, 2017
22.80 M USD
Jan 1, 2018
24.20 M USD
Jan 1, 2019
20.90 M USD
Jan 1, 2020
52.50 M USD
Jan 1, 2021
47.16 M USD
Jan 1, 2022
57.95 M USD
The Meridian Bioscience Current Liabilities history
YEARCurrent LiabilitiesYoY
57.95 MUSD+22.89%
47.16 MUSD-10.18%
52.50 MUSD+151.20%
20.90 MUSD-13.64%
24.20 MUSD+6.14%
22.80 MUSD+0.88%
22.60 MUSD+48.68%
15.20 MUSD+10.14%
13.80 MUSD-29.59%
19.60 MUSD+5.95%
18.50 MUSD+21.71%
15.20 MUSD+4.11%
14.60 MUSD-12.57%
16.70 MUSD+3.73%
16.10 MUSD-5.29%
17.00 MUSD-17.87%
20.70 MUSD+4.55%
19.80 MUSD+18.56%
16.70 MUSD+8.44%
15.40 MUSD+1.99%
15.10 MUSD-7.93%
16.40 MUSD-1.20%
16.60 MUSD+22.06%
13.60 MUSD+248.72%
3.90 MUSD-9.30%
4.30 MUSD-2.27%
4.40 MUSD+33.33%
3.30 MUSD-25.00%
4.40 MUSD+83.33%
2.40 MUSD+26.32%
1.90 MUSD+58.33%
1.20 MUSD-0.00%
1.20 MUSD+50.00%
800,000.00USD+33.33%
600,000.00USD-33.33%
900,000.00USD-10.00%
1.00 MUSD0.00%
1.00 MUSD
Access this data via the Eulerpool API

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

Current Liabilities of Meridian Bioscience is 57.95 M USD in 2026.

Current Liabilities of Meridian Bioscience changed from 47.16 M USD to 57.95 M USD, representing a 22.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Meridian Bioscience historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Meridian Bioscience

All Key Metrics — Meridian Bioscience